March 10, 2021

New COVID-19 Vaccine Might Be Option After Reactions to MRNA Versions

COVID-19 vaccine recipients who had a severe enough reaction to the first dose of mRNA vaccine to be unable to receive the second might have another option with emergency-use authorization of a third vaccine. Find out how and when those patients might be able to receive the Janssen (Johnson & Johnson) vaccine about a month out, according to the national CDC. 

Advertisement

Higher-Dose Semaglutide Shown Effective in Aiding T2D
Weight Loss

A higher dose of weekly injectable semaglutide than usually prescribed for type 2 diabetes (T2D) showed high effectiveness in helping patients slim down, with most dropping more than 5% of their body weight, according to a new study. Find out how much weight was lost compared to the usual dosage and a placebo. 

Inflammatory Bowel Disease Drugs Linked to Myeloid Clonal Disorder Risk

Thiopurines often are used to treat inflammatory bowel disease patients in an effort to maintain corticosteroid-free remission. A new study suggests a possible downside, however, with an increased risk for patients on the drugs to develop rare myeloid clonal disorders with poor prognosis. Here are more details.

Advertisement

DMT Dosing Adaptations Enhance COVID-19 Vaccination for Some MS Patients

Pharmacists may find themselves fielding questions from patients who are taking certain medications about the timing of injections of the COVID-19 vaccine. In the case of multiple sclerosis (MS) patients, some guidance was provided at a recent annual meeting of Americas Committee for Treatment and Research in Multiple Sclerosis. Here are the details. 

 
Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -